How the Giants’ $350 Million Carlos Correa Nightmare Became Their Greatest Escape

In the chaotic winter of 2022, the baseball world stopped spinning. The San Francisco Giants, fresh off a franchise-record 107-win season, had just landed the biggest fish in the free-agent pond: Carlos Correa. The contract was staggering—13 years, $350 million. It was the kind of signing that redefines a franchise. Then, in a twist that still echoes through the industry, the Giants pulled the plug. They cited medical concerns about Correa’s right ankle, a decision that drew ridicule, anger, and accusations of cold feet. Fast-forward to today, and that same decision has aged like a fine Napa Valley Cabernet. What was once viewed as a catastrophic organizational failure now looks like the most prescient move of the decade.

The Anatomy of an All-Time Shocker

To understand why this signing aged so well, we have to revisit the sheer audacity of the moment. When the Giants inked Correa to that $350 million pact, it was the largest contract in franchise history by a wide margin. The team was coming off a stunning 107-win season, but they had just lost shortstop Brandon Crawford to free agency. Correa, a World Series champion with the Houston Astros and a two-time All-Star, was supposed to be the bridge to a new dynasty.

But the shocker wasn’t just the money. It was the timing. The deal was announced, celebrated, and then—within days—unraveled. No contract of that magnitude had ever been rescinded so late in the process. The Giants’ front office, led by Farhan Zaidi, cited a physical exam that flagged Correa’s surgically repaired right ankle as a long-term risk. The baseball community called it a cop-out. Critics argued that the Giants were being overly cautious, that Correa had played 136 games in 2022 with no issues. The narrative was clear: San Francisco had fumbled the bag.

Correa, meanwhile, pivoted to the New York Mets, agreeing to a 12-year, $315 million deal. That, too, fell apart due to the same medical concerns. He eventually landed with the Minnesota Twins on a six-year, $200 million contract—still massive, but a far cry from the original guarantee. The Giants were left with egg on their faces and a gaping hole at shortstop.

The Medical Red Flags That Saved the Giants

Here is where the expert analysis kicks in. The Giants’ medical team didn’t just see a bad ankle. They saw a ticking clock. Correa’s right ankle had been a problem since 2014, when he suffered a fractured fibula and a torn deltoid ligament. He had surgery, but the joint was never the same. By 2023, the warning signs were impossible to ignore.

• Missed time: Correa played in just 135 games for the Twins in 2023, missing 27 games due to plantar fasciitis in his left foot—a compensatory issue often linked to altered mechanics from an unstable right ankle.
• Declining range: His defensive metrics at shortstop, once elite, dropped to below-average. His outs above average (OAA) fell from +8 in 2022 to -2 in 2023.
• Power dip: Correa hit 18 home runs in 2023, his lowest in a full season since 2019. His slugging percentage (.407) was his worst since his rookie year.

Compare that to what the Giants avoided. If Correa had signed that $350 million deal, he would have been a Giant through age 40. The back half of that contract, starting around 2028, would have been a financial anchor. The Giants would have been paying a declining, injury-prone player $27 million per year while trying to build around him. Instead, they used that money to sign Jung Hoo Lee and Matt Chapman, and they kept flexibility for future moves. The Twins, meanwhile, are already trying to figure out how to move Correa’s contract if his health continues to deteriorate.

How the Giants’ Loss Became Their Gain

The narrative that the Giants “lost” the Correa sweepstakes is outdated. In reality, they won the negotiation by losing it. Here’s why:

• Financial flexibility: The Giants avoided a contract that would have tied up 25% of their payroll for a decade. They used that room to sign Blake Snell (two years, $62 million) and Jung Hoo Lee (six years, $113 million), both of whom have outperformed Correa’s 2023 production on a per-dollar basis.
• Shortstop solution: Instead of Correa, the Giants pivoted to a platoon of Thairo Estrada and Casey Schmitt, then traded for Nick Ahmed in 2024. While not stars, they provided solid defense at a fraction of the cost.
• Cultural fit: Correa’s reputation as a polarizing figure—stemming from the Astros’ sign-stealing scandal—would have clashed with the Giants’ clubhouse culture. The team prides itself on chemistry and resilience, two traits that Correa’s presence might have disrupted.

The Mets dodged a similar bullet. After their deal with Correa collapsed, they pivoted to signing Kodai Senga and Justin Verlander, and while their 2023 season was a disaster, they avoided the long-term pain of a Correa albatross. The Twins, on the other hand, are now stuck with a player who has played just 220 games over two seasons and whose contract includes a full no-trade clause. For a mid-market team like Minnesota, that is a nightmare.

Predictions: What’s Next for Correa and the Giants

Looking ahead, the divergence between Correa’s trajectory and the Giants’ future is stark. Here are my predictions:

• Correa’s decline accelerates: By 2026, Correa will be a part-time player or a designated hitter. His ankle will force him to shift to third base, where his value drops significantly. The Twins will be forced to eat salary in a trade, likely sending cash to a contender for a mid-level prospect.
• Giants’ window opens: The Giants have built a young core around Lee, Chapman, and Logan Webb. With the payroll flexibility from the Correa non-signing, they can target a superstar like Juan Soto in free agency or make a blockbuster trade for a starting pitcher. The 2025-2027 window is wide open.
• Historical revisionism: In five years, the Correa non-signing will be taught in business schools as a case study in risk management. The Giants’ medical team will be hailed as heroes, and the phrase “the Correa rule” will enter baseball lexicon—referring to the importance of thorough physicals on mega-deals.

The lesson here is brutal but clear: sometimes the best deal is the one you don’t make. The Giants were ridiculed for walking away from $350 million worth of star power. But in a sport where long-term contracts are often millstones, San Francisco chose prudence over panic. Carlos Correa may still be a good player, but he will never be a great one again. And the Giants, by trusting their doctors and their instincts, avoided becoming the cautionary tale. Instead, they became the cautionary tale for everyone else—a reminder that in baseball, as in life, the biggest shocks are often the ones that save you.

This article originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.

Source: Based on news from Yahoo Sports.